References
E. Espinosa-Cárdenas, M. Sánchez-García, C. Ramírez-Rentería, V. Mendoza-Zubieta, E. Sosa-Eroza, M. Mercado, High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment? Endocrine 70, 143–149 (2020)
A. Elenkova, N. Genov, Z. Abadzhieva, V. Vasilev, K. Kalinov, S. Zachariena, Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance. Exp. Clin. Endocrinol. Diabetes 121, 201–205 (2013)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Espinosa-Cárdenas, E., Sánchez-García, M., Ramírez-Rentería, C. et al. Response to Letter to the Editor: “High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?”. Endocrine 71, 263–264 (2021). https://doi.org/10.1007/s12020-020-02584-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-020-02584-y